Helicobacter Pylori Diagnostics Market
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Helicobacter Pylori Diagnostics Market, By Test Type (Invasive (Immunoassay, Rapid Urease Test and Histology) and Non-invasive (Stool Antigen Assay, Serology Tests and Urea Breath Test)), By End Users (Hospitals, Clinics, Diagnostic Laboratories and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-of-care testing are major factors driving growth of Helicobacter pylori diagnostics market.
Market Dynamics
Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment.
Key features of the study
• This report provides in-depth analysis of the Helicobacter pylori diagnostics market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, product recalls, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global helicobacter pylori diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.
• The global Helicobacter pylori diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of helicobacter pylori diagnostic tests/devices, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the Helicobacter pylori diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Market Segmentation
• By Test Type (Revenue, USD Mn, 2021-2033)
o Invasive
Immunoassay
Rapid Urease Test
Histology
o Non-invasive
Stool Antigen Assay
Serology Tests
Urea Breath Test
• By End Users (Revenue, USD Mn, 2021-2033)
o Hospitals
o Clinics
o Diagnostic Laboratories
o Others
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Thermo Fisher Scientific, Inc.
o Bio-Rad Laboratories Inc.
o Diasorin S.P.A.
o Quidel Corporation
o Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
o Meridian Bioscience, Inc.
o Exalenz Bioscience Ltd.
o Abbott Laboratories
o Cardinal Health, Inc.
o Halyard Health, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Test Type
Market Snapshot, By End Users
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Helicobacter Pylori Diagnostics Market, By Test Type, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Invasive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Immunoassay
o Rapid Urease Test
o Histology
o Non-invasive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Stool Antigen Assay
o Serology Tests
o Urea Breath Test
5. Helicobacter Pylori Diagnostics Market, By End Users, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
6. Helicobacter Pylori Diagnostics Market, By Region, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Million)
o North Africa
o Central Africa
o South Africa
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Thermo Fisher Scientific, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bio-Rad Laboratories Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Diasorin S.P.A.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Quidel Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Meridian Bioscience, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Exalenz Bioscience Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abbott Laboratories
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cardinal Health, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Halyard Health, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們